Pava Partners has exclusively advised the shareholders of contextflow GmbH (“contextflow”) on the sale to 4DMedical Limited (“4DMedical”) (ASX: 4DX), a global leader in respiratory imaging technology. contextflow is an Austria-based category leader in AI-driven chest CT analysis to support radiologists in the detection of lung cancer and diagnosis of lung diseases.

The transaction provides 4DMedical with an immediate, comprehensive, on-the-ground commercial platform in Europe, significantly accelerating its global growth strategy and establishing operations across North America, Europe and Australia.

contextflow’s cutting-edge AI-based medical device software will complement and extend 4DMedical’s existing lung imaging portfolio, bringing structural + functional capabilities together for the first time.

contxtflow on Pava Partners

“contextflow represents a technology that is unrivalled globally – as the first and only radiology AI company with statutory health insurance reimbursement in Europe, with millions of proprietary medical imaging data points and a multi-year competitive lead. Communicating this value and guiding us throughout the competitive process with an international buyer like 4DMedical was truly valuable. We would like to thank Kevin Kissner and his team at Pava for their extraordinary commitment, their reliability, and for being by our side at every moment of the process,” says Markus Holzer, CEO and Co-founder of contextflow.